New zebrafish model should speed research on parasite that causes toxoplasmosis

May 15, 2015, Oregon State University
Toxoplasma gondii. Credit: Wikipedia

Researchers at Oregon State University have found a method to speed the search for new therapies to treat toxoplasmosis – by successfully infecting zebrafish with Toxoplasma gondii.

The findings were just published in the Journal of Fish Diseases, in work supported by the Tartar Foundation and the National Institutes of Health.

T. gondii, a , can infect a wide range of hosts, and is one of the most prevalent parasites in the world. It has been estimated to infect about one-third of the human race. Treatment can be difficult because parasites often have biologic similarities to the hosts they infect.

Zebrafish have been found in recent years to be an excellent model for biomedical research because they reproduce rapidly, bear many similarities to and biological systems, and can be used in "high throughput" technologies to literally test hundreds of compounds in a fairly short period of time.

"This advance may provide a very efficient tool for the discovery of new therapies for this parasitic infection," said Justin Sanders, an OSU postdoctoral fellow and lead author on the study. "With it we should be able to more easily screen a large library of compounds, at much less expense, and look at things that are unknown or have never been considered as a possible treatment."

Although it infects many animals, T. gondii infection has never been observed prior to this in fish. But the OSU researchers found that by raising the temperature of the water in which lived to a warmer-than-normal 98.6 degrees, or the temperature of a human body, they could become infected with the parasite but also survive.

"T. gondii affects a wide range of mammals and birds, and cats are actually one of the most routine hosts," said Michael Kent, a professor of microbiology in the OSU College of Science. "It can cause congenital defects, which is one reason that pregnant women are told not to clean the catbox. Many people become infected for life. These chronic infections can cause serious eye disease and can be fatal to people with weakened immune systems.

"New therapies would clearly be of value, and now we have a better way to find them," he said.

Explore further: New research offers the potential of new treatments for toxoplasma-induced pneumonia and cystic fibrosis

More information: "The zebrafish, Danio rerio, as a model for Toxoplasma gondii: an initial description of infection in fish." Journal of Fish Diseases. doi: 10.1111/jfd.12393

Related Stories

New research offers the potential of new treatments for toxoplasma-induced pneumonia and cystic fibrosis

April 29, 2015
The research has discovered a link between a vital pumping system that does not function correctly in people with cystic fibrosis and the parasite Toxoplasma.

Statin, osteoporosis drug combo may help treat parasitic infections

October 17, 2013
Researchers at the University of Georgia have discovered that a combination of two commonly prescribed drugs used to treat high cholesterol and osteoporosis may serve as the foundation of a new treatment for toxoplasmosis, ...

Hitting parasites where they hurt: New research shows promise in the fight against Toxoplasmosis

May 21, 2012
Toxoplasmosis, a disease caused by the parasite Toxoplasma gondii, is one of the most common parasitic infections in the world. In the U.S. it is estimated that more than 22 percent of the population 12 years and older have ...

Recommended for you

Zika may hijack mother-fetus immunity route

November 14, 2018
To cross the placenta, Zika virus may hijack the route by which acquired immunity is transferred from mother to fetus, new research suggests.

Maternally acquired Zika immunity can increase dengue disease severity in mouse pups

November 14, 2018
To say that the immune system is complex is an understatement: an immune response protective in one context can turn deadly over time, as evidenced by numerous epidemiological studies on dengue infection, spanning multiple ...

New research aims to help improve uptake of hepatitis C testing

November 14, 2018
New research published in Scientific Reports shows persisting fears about HIV infection may impact testing uptake for the hepatitis C Virus (HCV).

Discovery suggests new route to fight infection, disease

November 14, 2018
New research reveals how a single protein interferes with the immune system when exposed to the bacterium that causes Legionnaires' disease, findings that could have broad implications for development of medicines to fight ...

Synthetic DNA-delivered antibodies protect against Ebola in preclinical studies

November 13, 2018
Scientists at The Wistar Institute and collaborators have successfully engineered novel DNA-encoded monoclonal antibodies (DMAbs) targeting Zaire Ebolavirus that were effective in preclinical models. Study results, published ...

Scientists illuminate causes of hepatitis B virus-associated acute liver failure

November 13, 2018
National Institutes of Health scientists and their collaborators found that hepatitis B virus (HBV)-associated acute liver failure (ALF)—a rare condition that can turn fatal within days without liver transplantation—results ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.